Survey protocol for the ECDC genomic-based survey of carbapenem-resistant Acinetobacter baumannii in Europe v1.3

ECDC considers CRAb a key priority pathogen, amenable to ‘strategy-orientated surveillance’ as ‘sentinel surveillance or surveys’ of the ECDC European Antimicrobial Resistance Genes Surveillance Network (EURGen-Net). This ECDC survey protocol describes the technical requirements for implementing a genomic surveillance-based survey of CRAb isolates from patients seeking hospital care. It is intended for first use in 2024–2025.